Sexual Dimorphism in Neurodegenerative Diseases and in Brain Ischemia

Epidemiological studies and clinical observations show evidence of sexual dimorphism in brain responses to several neurological conditions. It is suggested that sex-related differences between men and women may have profound effects on disease susceptibility, pathophysiology, and progression. Sexual differences of the brain are achieved through the complex interplay of several factors contributing to this phenomenon, such as sex hormones, as well as genetic and epigenetic differences. Despite recent advances, the precise link between these factors and brain disorders is incompletely understood. This review aims to briefly outline the most relevant aspects that differ between men and women in ischemia and neurodegenerative disorders (AD, PD, HD, ALS, and SM). Recognition of disparities between both sexes could aid the development of individual approaches to ameliorate or slow the progression of intractable disorders.

[1]  L. Gan,et al.  X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women , 2022, Cell.

[2]  Sterling C. Johnson,et al.  An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease , 2022, Nature Aging.

[3]  V. Haroutunian,et al.  FSH blockade improves cognition in mice with Alzheimer’s disease , 2022, Nature.

[4]  Yafu Yin,et al.  Microglia Polarization From M1 to M2 in Neurodegenerative Diseases , 2022, Frontiers in Aging Neuroscience.

[5]  L. Gan,et al.  Sex Differences in Neurodegeneration: The Role of the Immune System in Humans , 2021, Biological Psychiatry.

[6]  K. Lunetta,et al.  Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer disease among women , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  Jose A. Santiago,et al.  Network Analysis Identifies Sex-Specific Gene Expression Changes in Blood of Amyotrophic Lateral Sclerosis Patients , 2021, International journal of molecular sciences.

[8]  N. Rocha,et al.  Sex Differences in Huntington's Disease: Evaluating the Enroll‐HD Database , 2021, Movement disorders clinical practice.

[9]  Stephen A. Goutman,et al.  Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner , 2021, Neurology: Neuroimmunology & Neuroinflammation.

[10]  R. Velazquez,et al.  Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis , 2021, Neurobiology of Aging.

[11]  C. Wahlestedt,et al.  Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research , 2021, Journal of Alzheimer's disease : JAD.

[12]  A. Nunomura,et al.  RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs , 2020, Oxidative medicine and cellular longevity.

[13]  Cassandra E. Meyer,et al.  Sex differences in brain atrophy in multiple sclerosis , 2020, Biology of sex differences.

[14]  Julie A. Harris,et al.  A second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease , 2020, Science Translational Medicine.

[15]  D. Hernandez,et al.  Differences in the Presentation and Progression of Parkinson's Disease by Sex , 2020, medRxiv.

[16]  J. Grose,et al.  The effects of diet and sex in amyotrophic lateral sclerosis. , 2020, Revue neurologique.

[17]  Filip Kosel,et al.  Behavioural and psychological symptoms of dementia in mouse models of Alzheimer’s disease-related pathology , 2020, Neuroscience & Biobehavioral Reviews.

[18]  E. Moro,et al.  Sex differences in movement disorders , 2020, Nature Reviews Neurology.

[19]  Lei Li,et al.  Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling , 2019, Journal of Neuroinflammation.

[20]  Yue-Ming Li,et al.  Friend, Foe or Both? Immune Activity in Alzheimer’s Disease , 2019, Front. Aging Neurosci..

[21]  H. Bramlett,et al.  Sexually dimorphic microglia and ischemic stroke , 2019, CNS neuroscience & therapeutics.

[22]  Joohyung Lee,et al.  Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson’s disease , 2019, Proceedings of the National Academy of Sciences.

[23]  James H. Faghmous,et al.  Huntington's disease in the United States: Variation by demographic and socioeconomic factors , 2019, Movement disorders : official journal of the Movement Disorder Society.

[24]  Keith A. Johnson,et al.  Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults , 2019, JAMA neurology.

[25]  Y. Ouyang,et al.  Elucidating sex differences in response to cerebral ischemia: immunoregulatory mechanisms and the role of microRNAs , 2019, Progress in Neurobiology.

[26]  Nicola Thrupp,et al.  The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques , 2019, Cell reports.

[27]  G. Manfredi,et al.  Sex Differences in Ischemia/Reperfusion Injury: The Role of Mitochondrial Permeability Transition , 2019, Neurochemical Research.

[28]  A. Chiò,et al.  Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials , 2019, Neurology.

[29]  J. Kriz,et al.  Brain Response to Injuries: When Microglia Go Sexist , 2019, Neuroscience.

[30]  S. Gold,et al.  Sex differences in autoimmune disorders of the central nervous system , 2018, Seminars in Immunopathology.

[31]  D. Bennett,et al.  Sex differences in Alzheimer’s disease and common neuropathologies of aging , 2018, Acta Neuropathologica.

[32]  L. McCullough,et al.  Sex differences in stroke: Challenges and opportunities , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Sterling C. Johnson,et al.  Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau , 2018, JAMA neurology.

[34]  N. Pedersen,et al.  Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.

[35]  Sterling C. Johnson,et al.  Sex-specific genetic predictors of Alzheimer’s disease biomarkers , 2018, Acta Neuropathologica.

[36]  K. Lenz,et al.  Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function , 2018, Front. Immunol..

[37]  A. Bentivoglio,et al.  The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease. , 2018, Parkinsonism & related disorders.

[38]  J. Matysik,et al.  Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease , 2018, Neurobiology of Aging.

[39]  R. Voskuhl,et al.  Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis , 2017, Brain : a journal of neurology.

[40]  R. Villa,et al.  Post‐stroke depression: Mechanisms and pharmacological treatment , 2017, Pharmacology & therapeutics.

[41]  L. Garcia-Segura,et al.  Sex differences in Parkinson’s disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics , 2017, Frontiers in Neuroendocrinology.

[42]  M. Mielke Sex and Gender Differences in Alzheimer's Disease Dementia. , 2018, The Psychiatric times.

[43]  L. Mosconi,et al.  Female Sex and Alzheimer’s Risk: The Menopause Connection , 2018, The Journal of Prevention of Alzheimer's Disease.

[44]  C. Angelini,et al.  Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration , 2017, Journal of the Neurological Sciences.

[45]  R. Gold,et al.  Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. , 2017, The American journal of pathology.

[46]  K. Suk,et al.  Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases , 2017, Front. Aging Neurosci..

[47]  Natalie V. Motta-Mena,et al.  Endocrinology of human female sexuality, mating, and reproductive behavior , 2017, Hormones and Behavior.

[48]  M. Colonna,et al.  Microglia Function in the Central Nervous System During Health and Neurodegeneration. , 2017, Annual review of immunology.

[49]  L. McCullough,et al.  Sex differences in ischaemic stroke: potential cellular mechanisms. , 2017, Clinical science.

[50]  A. ElAli,et al.  Complex Roles of Microglial Cells in Ischemic Stroke Pathobiology: New Insights and Future Directions , 2017, International journal of molecular sciences.

[51]  L. McCullough,et al.  Sex differences in neuroinflammation and neuroprotection in ischemic stroke , 2017, Journal of neuroscience research.

[52]  S. Weis,et al.  Sex‐dependent consequences of neonatal brain hypoxia‐ischemia in the rat , 2017, Journal of neuroscience research.

[53]  P. Libby,et al.  The Aging Cardiovascular System , 2017 .

[54]  E. Glaab,et al.  Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies , 2016, Molecular Neurobiology.

[55]  Tao Wu,et al.  The study of brain functional connectivity in Parkinson’s disease , 2016, Translational Neurodegeneration.

[56]  R. Prediger,et al.  Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms , 2016, Oxidative medicine and cellular longevity.

[57]  S. Klein,et al.  Sex differences in immune responses , 2016, Nature Reviews Immunology.

[58]  S. Gold,et al.  Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis , 2016, Neuroscience & Biobehavioral Reviews.

[59]  C. Pike,et al.  Obesity and sex interact in the regulation of Alzheimer's disease , 2016, Neuroscience & Biobehavioral Reviews.

[60]  M. Morissette,et al.  Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease , 2016, Neuroscience & Biobehavioral Reviews.

[61]  C. Gibson,et al.  The impact of gender on stroke pathology and treatment , 2016, Neuroscience & Biobehavioral Reviews.

[62]  G. Panzica,et al.  Structural and molecular brain sexual differences: A tool to understand sex differences in health and disease , 2016, Neuroscience & Biobehavioral Reviews.

[63]  Lin Yin,et al.  Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion , 2016, Neural regeneration research.

[64]  L. McCullough,et al.  Stroke sensitivity in the aged: sex chromosome complement vs. gonadal hormones , 2016, Aging.

[65]  T. Drake,et al.  Sex differences and hormonal effects on gut microbiota composition in mice , 2016, Gut microbes.

[66]  H. Shill,et al.  Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition , 2016, Journal of neuropathology and experimental neurology.

[67]  Paul M. Thompson,et al.  Age, APOE and sex: Triad of risk of Alzheimer’s disease , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[68]  G. Fiskum,et al.  Sex‐dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic‐ischemic encephalopathy , 2016, Journal of neurochemistry.

[69]  N. Jetté,et al.  The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis , 2016, Neuroepidemiology.

[70]  M. Lalancette-Hébert,et al.  Estrogen receptors alpha mediates postischemic inflammation in chronically estrogen-deprived mice , 2016, Neurobiology of Aging.

[71]  J. Chao,et al.  iNOS Induces Vascular Endothelial Cell Migration and Apoptosis Via Autophagy in Ischemia/Reperfusion Injury , 2016, Cellular Physiology and Biochemistry.

[72]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[73]  Xiongwei Zhu,et al.  Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer’s disease , 2016, Scientific Reports.

[74]  Angela M. Malek,et al.  The epidemiology of amyotrophic lateral sclerosis. , 2016, Handbook of clinical neurology.

[75]  P. Preux,et al.  Epidemiology of amyotrophic lateral sclerosis: A review of literature. , 2016, Revue neurologique.

[76]  S. Shimozaki,et al.  Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: A European population study. , 2016, Journal of psychosomatic research.

[77]  Sara Zarei,et al.  A comprehensive review of amyotrophic lateral sclerosis , 2015, Surgical neurology international.

[78]  Richard E. Brown,et al.  The problem of genotype and sex differences in life expectancy in transgenic AD mice , 2015, Neuroscience & Biobehavioral Reviews.

[79]  Joohyung Lee,et al.  Biological factors underlying sex differences in neurological disorders. , 2015, The international journal of biochemistry & cell biology.

[80]  N. Sharma,et al.  Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation , 2015, Neurochemistry International.

[81]  R. Giffard,et al.  IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice , 2015, Stroke.

[82]  M. McCarthy,et al.  A Starring Role for Microglia in Brain Sex Differences , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[83]  S. Mitra,et al.  Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson’s disease , 2015, Neuroscience.

[84]  R. Rigolio,et al.  Dihydrotestosterone as a Protective Agent in Chronic Experimental Autoimmune Encephalomyelitis , 2015, Neuroendocrinology.

[85]  Susan Kovats,et al.  Estrogen receptors regulate innate immune cells and signaling pathways , 2015, Cellular immunology.

[86]  You Li,et al.  MiR-206, a Key Modulator of Skeletal Muscle Development and Disease , 2015, International journal of biological sciences.

[87]  A. Arnold,et al.  Sex Differences in Ischemic Stroke Sensitivity Are Influenced by Gonadal Hormones, Not by Sex Chromosome Complement , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[88]  B. Trapp,et al.  Pathological mechanisms in progressive multiple sclerosis , 2015, The Lancet Neurology.

[89]  M. Schumacher,et al.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex , 2015, Glia.

[90]  Ornella Rimoldi,et al.  Coronary microvascular dysfunction: mechanisms and functional assessment , 2015, Nature Reviews Cardiology.

[91]  S. Appel,et al.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis , 2015, Neurotherapeutics.

[92]  J. Katzenellenbogen,et al.  Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis , 2014, Proceedings of the National Academy of Sciences.

[93]  M. Schumacher,et al.  cacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis , 2014 .

[94]  A. Yoshimura,et al.  Post-ischemic inflammation regulates neural damage and protection , 2014, Front. Cell. Neurosci..

[95]  Kara M. Smith,et al.  Sex differences in Parkinson's disease and other movement disorders , 2014, Experimental Neurology.

[96]  K. Bertram,et al.  Sex differences in Parkinson’s disease , 2014, Journal of Clinical Neuroscience.

[97]  G. Gillies,et al.  Sex differences in Parkinson’s disease , 2014, Frontiers in Neuroendocrinology.

[98]  Rena Li,et al.  Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.

[99]  P. Mccombe,et al.  Gender differences in autoimmune disease , 2014, Frontiers in Neuroendocrinology.

[100]  F. Sohrabji,et al.  Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. , 2014, Clinical science.

[101]  D. Brites,et al.  Microglia centered pathogenesis in ALS: insights in cell interconnectivity , 2014, Front. Cell. Neurosci..

[102]  E. Giltay,et al.  Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY) , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[103]  J. Correale The role of microglial activation in disease progression , 2014, Multiple sclerosis.

[104]  R. D. Du Pasquier,et al.  Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis , 2014, CNS Drugs.

[105]  Andre Altmann,et al.  Sex modifies the APOE‐related risk of developing Alzheimer disease , 2014, Annals of neurology.

[106]  E. Fish,et al.  SeXX matters in immunity. , 2014, Trends in immunology.

[107]  T. Chitnis,et al.  The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis , 2014, Multiple sclerosis.

[108]  P. Ostadal,et al.  Sex‐based differences in cardiac ischaemic injury and protection: therapeutic implications , 2014, British journal of pharmacology.

[109]  S. Soyal,et al.  A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort , 2014, BMC Neurology.

[110]  A. Churchyard,et al.  Aggression in Huntington's disease: a systematic review of rates of aggression and treatment methods. , 2014, Journal of Huntington's disease.

[111]  S. Kumar,et al.  Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand , 2013, Proceedings of the National Academy of Sciences.

[112]  Jane S. Paulsen,et al.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. , 2013, Journal of psychiatric research.

[113]  Chandler R. L. Mongerson,et al.  Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons , 2013, The Journal of Neuroscience.

[114]  Shao-Hua Yang,et al.  Window of opportunity: Estrogen as a treatment for ischemic stroke , 2013, Brain Research.

[115]  Xiaonan H. Wang MicroRNA in myogenesis and muscle atrophy , 2013, Current opinion in clinical nutrition and metabolic care.

[116]  J. Gustafsson,et al.  Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis , 2013, Proceedings of the National Academy of Sciences.

[117]  C. Pike,et al.  Gender, sex steroid hormones, and Alzheimer's disease , 2013, Hormones and Behavior.

[118]  H. Putter,et al.  The influence of gender on phenotype and disease progression in patients with Huntington's disease. , 2013, Parkinsonism & related disorders.

[119]  Bartosz Bielecki,et al.  The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. , 2013, Brain : a journal of neurology.

[120]  J. Veldink,et al.  Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis , 2013, Journal of Neurology.

[121]  L. McCullough,et al.  Interactions between age, sex, and hormones in experimental ischemic stroke , 2012, Neurochemistry International.

[122]  F. Campos,et al.  GDNF Contributes to Oestrogen‐Mediated Protection of Midbrain Dopaminergic Neurones , 2012, Journal of neuroendocrinology.

[123]  N. Jetté,et al.  The incidence and prevalence of Huntington's disease: A systematic review and meta‐analysis , 2012, Movement disorders : official journal of the Movement Disorder Society.

[124]  C. Pike,et al.  Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice , 2012, Brain Research.

[125]  A. Hannan,et al.  Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease , 2012, Translational Psychiatry.

[126]  Giovanni Coppola,et al.  Gender Modulates the APOE ε4 Effect in Healthy Older Adults: Convergent Evidence from Functional Brain Connectivity and Spinal Fluid Tau Levels , 2012, The Journal of Neuroscience.

[127]  J. Trojanowski,et al.  Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. , 2012, Brain : a journal of neurology.

[128]  A. Hannan,et al.  Deficits in Spermatogenesis but not Neurogenesis are Alleviated by Chronic Testosterone Therapy in R6/1 Huntington’s Disease Mice , 2012, Journal of neuroendocrinology.

[129]  E. Mufson,et al.  Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice , 2012, Neurobiology of Disease.

[130]  R. Voskuhl,et al.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration , 2012, Frontiers in Neuroendocrinology.

[131]  S. Amor,et al.  Multiple sclerosis: Neuroprotective alliance of estrogen–progesterone and gender , 2012, Frontiers in Neuroendocrinology.

[132]  M. Tabaton,et al.  Amyloid-β Production: Major Link Between Oxidative Stress and BACE1 , 2012, Neurotoxicity Research.

[133]  D. Aarsland,et al.  Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease , 2012, Journal of Neurology.

[134]  I. Tendolkar,et al.  Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender , 2011, Journal of the Neurological Sciences.

[135]  K. Langa,et al.  Incidence of dementia and cognitive impairment, not dementia in the united states , 2011, Annals of neurology.

[136]  L. Lanfumey,et al.  Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression , 2011, PloS one.

[137]  H. Weiner,et al.  Demographic and clinical characteristics of malignant multiple sclerosis , 2011, Neurology.

[138]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[139]  Andrew C. Li,et al.  An ADIOL-ERβ-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation , 2011, Cell.

[140]  L. McCullough,et al.  Estrogen Enhances Neurogenesis and Behavioral Recovery after Stroke , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[141]  Pamela A McCombe,et al.  Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.

[142]  Erik Sahai,et al.  Deficits in axonal transport precede ALS symptoms in vivo , 2010, Proceedings of the National Academy of Sciences.

[143]  C. Pike,et al.  Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways , 2010, Brain Research.

[144]  Bingbing Song,et al.  Oestrogen receptor b ligand : a novel treatment to enhance endogenous functional remyelination , 2010 .

[145]  L. Goldstein,et al.  The sex ratio in amyotrophic lateral sclerosis: A population based study , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[146]  R. Rozmahel,et al.  Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease , 2010, Neuroscience.

[147]  M. Amato,et al.  Cognitive impairment in early stages of multiple sclerosis , 2010, Neurological Sciences.

[148]  C. Pike,et al.  Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. , 2010, Endocrinology.

[149]  G. Gillies,et al.  Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women: A Case for Sex-Specific Medicines , 2010, Pharmacological Reviews.

[150]  F. Gonzalez-Lima,et al.  Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1 G93A ALS mouse model , 2009, Neuroscience.

[151]  John McAnally,et al.  MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice , 2009, Science.

[152]  C. Colton Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.

[153]  Cristian Sirbu,et al.  Testosterone and Depression: Systematic Review and Meta-Analysis , 2009, Journal of psychiatric practice.

[154]  K. Ono,et al.  Anti-aggregation and fibril-destabilizing effects of sex hormones on α-synuclein fibrils in vitro , 2009, Experimental Neurology.

[155]  Ludovico Minati,et al.  Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review , 2009, American journal of Alzheimer's disease and other dementias.

[156]  T. Toung,et al.  Age-Dependent Effects of Testosterone in Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[157]  S. Çitak,et al.  Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial. , 2009, Maturitas.

[158]  A. Hannan,et al.  Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. , 2009, Human molecular genetics.

[159]  L. McCullough,et al.  Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[160]  J. Studd,et al.  Are oestrogens useful for the treatment of depression in women? , 2009, Best practice & research. Clinical obstetrics & gynaecology.

[161]  H. Fullerton,et al.  Male Predominance in Childhood Ischemic Stroke: Findings From the International Pediatric Stroke Study , 2009, Stroke.

[162]  Andreas Bauer,et al.  Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. , 2008, Human molecular genetics.

[163]  S. Callier,et al.  Estrogen and SERM neuroprotection in animal models of Parkinson's disease , 2008, Molecular and Cellular Endocrinology.

[164]  B. Gwag,et al.  Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice , 2008, Journal of the Neurological Sciences.

[165]  C. Pike,et al.  Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. , 2008, Endocrinology.

[166]  J. Simpkins,et al.  Mitochondrial mechanisms of estrogen neuroprotection , 2008, Brain Research Reviews.

[167]  C. Charriaut-Marlangue,et al.  Gender-Related Differences in Apoptotic Pathways After Neonatal Cerebral Ischemia , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[168]  D. Reich,et al.  Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis , 2008, American Journal of Neuroradiology.

[169]  Jane S. Paulsen,et al.  Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study , 2007, Biological Psychiatry.

[170]  Adama Brown,et al.  Depression in multiple sclerosis: a longitudinal analysis. , 2007, Archives of psychiatric nursing.

[171]  F. Groenendaal,et al.  Gender-Dependent Pathways of Hypoxia-Ischemia-Induced Cell Death and Neuroprotection in the Immature P3 Rat , 2007, Developmental Neuroscience.

[172]  B. Liu,et al.  OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE , 2007, Clinical and experimental pharmacology & physiology.

[173]  Sara Marceglia,et al.  Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation , 2007, Movement disorders : official journal of the Movement Disorder Society.

[174]  M. Panas,et al.  Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease. , 2007, Neuro endocrinology letters.

[175]  G. Rebec,et al.  Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease , 2007, Behavioural Brain Research.

[176]  F. Gage,et al.  Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors α and β , 2007 .

[177]  L. Sklar,et al.  GPR30: A G protein-coupled receptor for estrogen , 2007, Molecular and Cellular Endocrinology.

[178]  L. Berliocchi,et al.  Evidence to implicate early modulation of interleukin-1beta expression in the neuroprotection afforded by 17beta-estradiol in male rats undergone transient middle cerebral artery occlusion. , 2007, International review of neurobiology.

[179]  Frank M LaFerla,et al.  Androgens Regulate the Development of Neuropathology in a Triple Transgenic Mouse Model of Alzheimer's Disease , 2006, The Journal of Neuroscience.

[180]  Bastiaan R Bloem,et al.  Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[181]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[182]  C. Tanner,et al.  Effect of Reproductive Factors and Postmenopausal Hormone Use on the Risk of Amyotrophic Lateral Sclerosis , 2006, Neuroepidemiology.

[183]  C. Tirolo,et al.  Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration , 2006, Neuroscience.

[184]  C. Tanner,et al.  Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease , 2005, Neurology.

[185]  J. Ávila,et al.  Estradiol Prevents Neural Tau Hyperphosphorylation Characteristic of Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.

[186]  E. Eriksson,et al.  Investigation of genes coding for inflammatory components in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[187]  T. Shirasawa,et al.  Estrogen, Insulin, and Dietary Signals Cooperatively Regulate Longevity Signals to Enhance Resistance to Oxidative Stress in Mice* , 2005, Journal of Biological Chemistry.

[188]  M. Panas,et al.  Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia , 2005, Annals of neurology.

[189]  L. V. D. Berg,et al.  Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. , 2004, Brain research.

[190]  J Melke,et al.  Association between the estrogen receptor beta gene and age of onset of Parkinson’s disease , 2004, Psychoneuroendocrinology.

[191]  D. Dexter,et al.  Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease , 2004, Pharmacology Biochemistry and Behavior.

[192]  H. Braak,et al.  The Biphasic Relationship between Regional Brain Senile Plaque and Neurofibrillary Tangle Distributions: Modification by Age, Sex, and APOE Polymorphism , 2004, Annals of the New York Academy of Sciences.

[193]  Joanne M. Smith,et al.  Stroke in the female: role of biological sex and estrogen. , 2004, ILAR journal.

[194]  S. Cheema,et al.  Antisense peptide nucleic acid‐mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice , 2003, Journal of neurochemistry.

[195]  M. Tarnopolsky,et al.  Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice , 2003, Neuroscience.

[196]  L. McCullough,et al.  Estrogen and ischemic neuroprotection: an integrated view , 2003, Trends in Endocrinology & Metabolism.

[197]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[198]  P. Adeleine,et al.  Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.

[199]  C. Pike,et al.  Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.

[200]  Wenyin Chen,et al.  Estrogen attenuates tumor necrosis factor-α expression to provide ischemic neuroprotection in female rats , 2002, Neuroscience Letters.

[201]  A. Herbison,et al.  Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice. , 2002, Brain research. Molecular brain research.

[202]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[203]  L. Shulman Is there a connection between estrogen and Parkinson's disease? , 2002, Parkinsonism & related disorders.

[204]  D. Schaid,et al.  Case‐control study of estrogen receptor gene polymorphisms in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[205]  S. Asthana,et al.  High-dose estradiol improves cognition for women with AD , 2001, Neurology.

[206]  J. Troncoso,et al.  The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender , 2001, Neurobiology of Aging.

[207]  Ling Wang,et al.  Morphological abnormalities in the brains of estrogen receptor β knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[208]  T. Foroud,et al.  Progression of symptoms in the early and middle stages of Huntington disease. , 2001, Archives of neurology.

[209]  H C Liu,et al.  Effects of estrogen on cognition, mood, and cerebral blood flow in AD , 2000, Neurology.

[210]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[211]  B L Miller,et al.  Estrogen for Alzheimer’s disease in women , 2000, Neurology.

[212]  E. Siemers,et al.  Rate of functional decline in Huntington’s disease , 2000, Neurology.

[213]  C. Cotman,et al.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. , 2000, JAMA.

[214]  M. Owen,et al.  Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length , 1999, Journal of medical genetics.

[215]  J. O'Callaghan,et al.  The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity , 1998, Annals of the New York Academy of Sciences.

[216]  R. Traystman,et al.  Gender-linked brain injury in experimental stroke. , 1998, Stroke.

[217]  R B D'Agostino,et al.  Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.

[218]  D. Dluzen,et al.  Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. , 1996, Neurotoxicology and teratology.

[219]  R. Stelzmann,et al.  An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.

[220]  Joseph B. Martin Huntington's disease , 1984, Neurology.